Valuation: Pathkey.AI Ltd

Market Cap 41.28M 28.65M 25.05M 22.99M 21.44M 40.64M 2.73B 276M 107M 1.34B 108M 105M 4.62B P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 41.26M 28.63M 25.03M 22.97M 21.43M 40.61M 2.73B 276M 107M 1.34B 107M 105M 4.62B EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
1 day-6.06%
1 week+3.33%
Current month-8.82%
1 month+58.97%
3 months+181.82%
6 months+287.50%
Current year+287.50%
1 week 0.06
Extreme 0.061
0.08
1 month 0.04
Extreme 0.037
0.08
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3.4
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1994-01-16
Chief Executive Officer - 2026-05-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2025-10-20
Director/Board Member - 2025-10-20
Chairman - 2025-11-25
Change 5-day change 1-year change 3-year change Capi.($)
-6.06%+3.33%+121.43%+181.82% 27.78M
+4.62%+21.93%-31.80%-2.52% 31.31B
+1.81%+13.09%-26.49%+219.39% 14.91B
+0.48%+6.94%-14.06%+63.52% 5.87B
-8.94%-20.05% - - 2.41B
+5.52%+6.03% - - 2.23B
+2.62%+8.85%+44.40%-41.59% 1.96B
-8.30%-7.61%-28.45% - 1.24B
-0.34%+12.82%-30.52%+267.14% 828M
+1.54%+1.54%-40.75%-60.62% 741M
Average -0.70%+6.10%-0.78%+89.59% 6.15B
Weighted average by Cap. +2.61%+14.40%-25.91%+65.87%

Financials

2024 2025
Net sales 398K 276K 241K 221K 207K 391K 26.27M 2.66M 1.03M 12.91M 1.04M 1.01M 44.53M 322K 223K 195K 179K 167K 317K 21.27M 2.15M 838K 10.45M 839K 821K 36.06M
Net income -3.13M -2.17M -1.9M -1.74M -1.63M -3.08M -207M -20.95M -8.15M -102M -8.16M -7.98M -351M -1.45M -1M -878K -806K -752K -1.43M -95.65M -9.69M -3.77M -47M -3.77M -3.69M -162M
Net Debt -375K -260K -227K -209K -195K -369K -24.75M -2.51M -975K -12.16M -976K -955K -41.96M -25.17K -17.47K -15.27K -14.01K -13.07K -24.77K -1.66M -168K -65.5K -817K -65.57K -64.14K -2.82M
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
26-07-03 A$0.0620 -6.06% 5,221,326
26-07-02 A$0.0660 +3.13% 2,340,926
26-07-01 A$0.0640 -5.88% 3,233,389
26-06-30 A$0.0680 +4.62% 4,360,629
26-06-29 A$0.0650 -8.45% 16,541,655